These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15001208

  • 1. Spironolactone for the treatment of isolated systolic hypertension.
    Yarows SA.
    Am J Hypertens; 2004 Mar; 17(3):284. PubMed ID: 15001208
    [No Abstract] [Full Text] [Related]

  • 2. Aldosterone antagonist therapy in resistant hypertension.
    Zannad F.
    J Hypertens; 2007 Apr; 25(4):747-50. PubMed ID: 17351364
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.
    Ogawa S, Takeuchi K, Mori T, Nako K, Ito S.
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(5-6):477-9. PubMed ID: 16700881
    [Abstract] [Full Text] [Related]

  • 6. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
    Zarnegar R, Lee J, Brunaud L, Lindsay S, Kebebew E, Clark OH, Duh QY.
    Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
    [Abstract] [Full Text] [Related]

  • 7. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A, Feely J.
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adding low-dose spironolactone to multidrug regimens for resistant hypertension.
    Berecek KH, Farag A, Bahtiyar G, Rothman J, McFarlane SI.
    Curr Hypertens Rep; 2004 Jun; 6(3):211-2. PubMed ID: 15128473
    [No Abstract] [Full Text] [Related]

  • 10. Spironolactone management of resistant hypertension.
    Marrs JC.
    Ann Pharmacother; 2010 Nov; 44(11):1762-9. PubMed ID: 20978214
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M, Bellone JM, Wright BM, Rutecki GW.
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.
    Sharabi Y, Adler E, Shamis A, Nussinovitch N, Markovitz A, Grossman E.
    Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hypertension in patients with diabetes].
    Poulsen PL, Hansen KW, Gaede PH, Rossing P.
    Ugeskr Laeger; 2009 Jun 08; 171(24):2031-4. PubMed ID: 19523370
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of aldosterone antagonists in resistant hypertension.
    Calhoun DA.
    Prog Cardiovasc Dis; 2006 Jun 08; 48(6):387-96. PubMed ID: 16714158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.